Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
Background Current immunotherapies still have limited successful rates among cancers. It is now recognized that T cell functional state in the tumor microenvironment (TME) is a key determinant for effective antitumor immunity and immunotherapy. In addition to exhaustion, cellular senescence in tumor...
Saved in:
Main Authors: | Xia Liu, Emily Shaw, Fusheng Si, Guangyong Peng, Yan Tao, Feiya Ma, David Bagley, Yuanqin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-10-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/10/e005020.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Cancer Immunotherapies and Antitumor Immunity
by: Lei Zhao, et al.
Published: (2019-01-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01) -
Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response
by: John Reiser, et al.
Published: (2016-01-01) -
Specific types of male infertility are correlated with T cell exhaustion or senescence signatures
by: Giada Amodio, et al.
Published: (2025-01-01) -
Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity
by: Xiubao Ren
Published: (2025-01-01)